Inner Mongolia Furui Medical Science Co., Ltd. (SHE:300049)
China flag China · Delayed Price · Currency is CNY
40.33
-1.48 (-3.54%)
Nov 17, 2026, 3:04 PM CST

SHE:300049 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
175.96154.09113.29101.5697.8995.47
Depreciation & Amortization
101.43101.4391.1280.972.3967.05
Other Amortization
3.43.43.999.323.921.17
Loss (Gain) From Sale of Assets
-0.38-0.380.310.821.863.46
Asset Writedown & Restructuring Costs
32.5432.547.74.710-
Loss (Gain) From Sale of Investments
-16.83-16.8323.11-2.53-4.12-5.74
Provision & Write-off of Bad Debts
-1.91-1.9119.791.556.588.95
Other Operating Activities
177.6140.8678.4471.8449.154.9
Change in Accounts Receivable
-120.63-120.63-106.26-24.6-94.93-85
Change in Inventory
-9.52-9.52-38.15-4.62-3.094.17
Change in Accounts Payable
62.5162.5118.1368.8266.7657.31
Change in Other Net Operating Assets
7.557.5519.42---
Operating Cash Flow
410.14351.53221.41304.89189.46222.55
Operating Cash Flow Growth
31.14%58.77%-27.38%60.92%-14.87%11.19%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-164.5-189.01-218.97-189.23-90.78-79.61
Sale of Property, Plant & Equipment
4.694.454.972.731.862.01
Cash Acquisitions
--18.750.950.62-0.12
Divestitures
---0.83--
Investment in Securities
-104.23-2.4-120.07-7.012.84-116.28
Other Investing Activities
-3.54-26.078.9341.317.0111.44
Investing Cash Flow
-267.58-213.03-306.38-150.43-68.45-182.56

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Short-Term Debt Issued
---16.332.8147.97
Long-Term Debt Issued
-12.421.67---
Total Debt Issued
62.9912.421.6716.332.8147.97
Short-Term Debt Repaid
----11.99-51.13-69.89
Long-Term Debt Repaid
--25.86-19.72-9.5-11.36-14.24
Lease Payments
-25.86-25.86-19.72-9.5-11.36-14.24
Total Debt Repaid
-25.86-25.86-19.72-21.49-62.49-84.13
Net Debt Issued (Repaid)
37.13-13.461.95-5.16-59.68-36.16
Issuance of Common Stock
--183.05--26.6
Repurchase of Common Stock
-21.42-21.42-4.07---
Common Dividends Paid
-20.21-2.29-2.2-53.42-71.41-1.95
Other Financing Activities
-40.25-33.09-40.21-78.574.564.85
Financing Cash Flow
-44.74-70.26138.52-137.14-126.54-6.65

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-41.1412.26-3.3513.0612.01-28.52
Net Cash Flow
56.6780.4950.230.386.494.82

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
245.64162.512.44115.6698.69142.94
Free Cash Flow Growth
147.37%6555.09%-97.89%17.20%-30.96%58.11%
Free Cash Flow Margin
15.02%10.19%0.18%10.03%9.78%15.91%
Free Cash Flow Per Share
0.920.610.010.440.380.55
Levered Free Cash Flow
432.44263.85-17.1361.0634.29102.67
Unlevered Free Cash Flow
435.12265.87-15.4161.6235.28104.12
Free Cash Flow After Leases
219.78136.65-17.28106.1687.33128.7

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
153.17135.45122.56102.3189.3952.05
Change in Working Capital
-61.67-61.67-116.3336.73-38.17-2.71